V2 receptor-mediated regulation of aquaporin-2 by oxytocin in the kidney.
- Author:
Un Sil JEON
1
;
Ki Young NA
;
Yoon Kyu OH
;
Jin Suk HAN
;
Jung Sang LEE
;
Kwon Wook JOO
;
Jin KIM
;
Gheun Ho KIM
Author Information
1. Department of Internal Medicine, Gyeong-sang National University College of Medicine, Chinju, Korea.
- Publication Type:Original Article
- Keywords:
Oxytocin;
Aquaporins;
Receptor;
Vasopressin;
Kidney;
Cell membrane
- MeSH:
Animals;
Aquaporin 2*;
Aquaporins;
Cell Membrane;
Cytoplasm;
Cytoplasmic Vesicles;
Immunoblotting;
Immunohistochemistry;
Injections, Intraperitoneal;
Kidney*;
Membranes;
Oxytocin*;
Permeability;
Pituitary Gland, Posterior;
Plasma;
Rats;
Rats, Sprague-Dawley;
Vasopressins;
Water
- From:Korean Journal of Medicine
2002;62(3):268-277
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Oxytocin is a nonapeptide hormone secreted from posterior pituitary gland and has a very similar structure to vasopressin. The aquaporin-2 (AQP2) water channel is predominantly expressed in the kidney and plays a key role in regulation of water permeability of mammalian collecting duct, exerted by both short-term and long-term vasopressin action. We speculated that oxytocin may be involved in some part of vasopressin-independent urinary concentrating mechanism by regulating AQP2 trafficking in the kidney. METHODS: This study was undertaken to investigate whether and how the acute stimulation of oxytocin induces changes in AQP2 localization in the kidney. Immunohistochemistry and semiquantitative immunoblotting of AQP2 were carried out from Sprague-Dawley rat kidneys after a single intraperitoneal injection of oxytocin with or without pretreatment of a vasopressin-2 receptor (V2R) antagonist. RESULTS: Urinary cAMP excretion was increased by oxytocin administration. Immuno- histochemistry of inner medullary collecting duct (IMCD) revealed that AQP2 was shifted from diffuse cytoplasmic localization in controls to the apical and basolateral membrane domains in oxytocin-treated rats. This pattern of AQP2 redistribution was noted in connecting tubule, cortical collecting duct and outer medullary collecting duct as in IMCD, although the tendency to basolateral localization was somewhat less. Semiquantitative immunoblotting of membrane fractions of whole kidney homogenates was also used to assess redistribution of AQP2. The band density ratio of the plasma membrane-rich fraction over cytoplasmic vesicle-rich fraction was higher in oxytocin-treated rats than in controls (3.64+/-0.60 vs. 1.09+/-0.14, P<0.05). Regarding the receptor pathway of oxytocin action in the kidney, we found that pretreatment with a V2R antagonist (OPC-31260) blocked redistribution of AQP2 which was induced by oxytocin. CONCLUSION: In conclusion, oxytocin induces a V2R-mediated redistribution of AQP2-containing cytoplasmic vesicles to both apical and basolateral plasma membrane domains in rat kidney. Oxytocin may be one of the factors that accounts for vasopressin-independent AQP2 targeting in the kidney.
